Sign up for our newsletter and get the latest big data news and analysis.

3 Reasons How Natural Language Processing Can Help Healthcare Providers

In this special guest feature, Ravi Gopalan, Founder & Chief Technology Officer at Binary Fountain, discusses how healthcare providers can begin to understand and act on the increasing amount of data with patient feedback management solutions using healthcare-specific natural language processing (NLP).

How NLP Can Help Healthcare “Catch Up”

In this special guest feature, Simon Beaulah, Senior Director of Healthcare at Linguamatics, discusses how natural language processing (NLP) has become a crucial tool in healthcare and the life sciences as these sectors struggle to catch up to other industries and transform their big data into actionable data.

Medable Launches Cloud-Based Machine Learning Solution for Healthcare

MEDABLE Inc., a leading application and analytics platform for healthcare, announced Cerebrum, the first cloud-based machine learning solution created specifically for healthcare apps. Cerebrum leverages data gathering smartphones with a first-of-its-kind machine learning engine, resulting in health events becoming more easily predicted, such as warning an elderly relative when he is at greatest risk of a fall, or preventing an asthmatic child from triggering a life threatening episode.

Data Systems Strategies for Today’s Challenges

To address today’s challenges and come up with viable data systems strategies, pharmaceutical companies are looking outside the industry to leverage scientific and technical innovation in other markets.

Commercial Analytics and It’s Defining Role In Pharma Marketing

Pharma companies are working hard to build effective patient access programs and implement an effective commercial strategy around it. Expiring patents and competitive pressure is a real challenge and companies need to explore opportunities with the help of the vast amounts of data they own. Big Data and Analytics capabilities are helping companies define that strategy and execute a plan, which will help them succeed. Our friends over at Prescriber360 put together the infographic below containing facts and figures to emphasize the need of a well-planned analytics strategy.

Why Big Data Means Better Health

In this special guest feature, Souvik Das, Senior VP of Engineering at Grand Rounds, discusses how big data will open up the opportunity for physicians to impact patients anywhere in the world, all from a single interface or digitized platform. In turn, patients will also become better informed of the right doctor and treatment path for their unique needs.

Data-Driven Healthcare: A Proactive Revolution

In this special guest feature, Richard Proctor, GM of Global Healthcare at Hortonworks, discusses how big data is enabling key healthcare organizations including UNOS, MD Anderson and Arizona State University to manage chronic diseases, improve overall member health, reduce costs, and manage clinical and financial risk.

Artificial Intelligence App Game Changer for Health Care Technology in the US

Health technology company Ada has brought a new artificial intelligence (AI) powered health companion to the US, providing Americans with a more personalized way to assess and monitor their health. Designed to grow smarter as users engage with it, Ada’s intelligence not only offers users a sophisticated and tailored health assessment, ­ it also supports […]

Government Sponsored Data Analytics in Healthcare and Life Sciences

The insideBIGDATA Guide to Data Analytics in Government provides an in-depth overview of the use of data analytics technology in the public sector. Focus is given to how data analytics is being used in the government setting with a number of high-profile use case examples. This is the third in a series of articles providing content extracted from the guide. The topic for this segment is government sponsored data analytics in healthcare and life sciences.

FDA’s Next Frontier: Regulating Machine Learning in Clinical Decision Support Software

In this special guest feature, Bradley Merrill Thompson, a partner in the Washington DC office of law firm Epstein Becker & Green and Chairman of the Board of the firm’s consulting affiliate EBG Advisors, starts a compelling and timely conversation on the FDA’s approach to regulating machine learning.